ATE193726T1 - Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung - Google Patents

Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung

Info

Publication number
ATE193726T1
ATE193726T1 AT92302004T AT92302004T ATE193726T1 AT E193726 T1 ATE193726 T1 AT E193726T1 AT 92302004 T AT92302004 T AT 92302004T AT 92302004 T AT92302004 T AT 92302004T AT E193726 T1 ATE193726 T1 AT E193726T1
Authority
AT
Austria
Prior art keywords
nucleotide sequence
specific nucleotide
containing specific
strain containing
measles virus
Prior art date
Application number
AT92302004T
Other languages
English (en)
Inventor
Keiko Sasaki
Takayuki Mori
Satoshi Makino
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of ATE193726T1 publication Critical patent/ATE193726T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18421Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT92302004T 1991-10-14 1992-03-10 Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung ATE193726T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3293625A JP3045581B2 (ja) 1991-10-14 1991-10-14 麻疹ワクチンウイルス株同定方法

Publications (1)

Publication Number Publication Date
ATE193726T1 true ATE193726T1 (de) 2000-06-15

Family

ID=17797135

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92302004T ATE193726T1 (de) 1991-10-14 1992-03-10 Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung

Country Status (10)

Country Link
US (2) US5654136A (de)
EP (1) EP0540135B1 (de)
JP (1) JP3045581B2 (de)
KR (1) KR950012759B1 (de)
AT (1) ATE193726T1 (de)
DE (1) DE69231143T2 (de)
DK (1) DK0540135T3 (de)
ES (1) ES2148164T3 (de)
GR (1) GR3034278T3 (de)
PT (1) PT540135E (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0635056A1 (de) * 1992-04-08 1995-01-25 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Glykoproteine des natürlichen Masern-Virus: Impfstoff und entsprechende Nachweismethode
US6638482B1 (en) * 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
DE69716609T2 (de) * 1996-07-31 2003-07-03 Claude P. Muller Peptide abgeleitet aus dem morbillivirus
CA2265554A1 (en) * 1996-09-27 1998-04-02 American Cyanamid Company 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
JP4043054B2 (ja) 1997-06-04 2008-02-06 財団法人阪大微生物病研究会 変異麻疹ウイルス抗原及びそれをコードする遺伝子
CA2323927A1 (en) * 1998-03-26 1999-09-30 American Cyanamid Company Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
US6875436B1 (en) * 1999-11-19 2005-04-05 The Kitasata Institute Method for producing cell-fushion type morbillivirus mutants
KR100441459B1 (ko) * 2000-01-31 2004-07-23 사이단호진한다이비세이부쯔뵤우겐큐우카이 약독 생수두백신의 품질 관리 방법
CA2399504C (en) * 2000-02-10 2011-02-22 The Kitasato Institute Methods for producing temperature-sensitive morbillivirus
EP1375670B1 (de) 2002-06-20 2013-06-12 Institut Pasteur Rekombinante Masernviren, welche Epitope der Antigene von RNA-Viren exprimieren, sowie die Verwendung der rekombinanten Viren zur Herstellung von Impfstoffen
DK1375512T3 (da) * 2002-06-20 2009-10-26 Pasteur Institut Infektiös cDNA af en godkendt vaccinestamme af mæslingevirus. Anvendelse til immunogene sammensætninger
CA2432738A1 (en) 2003-02-26 2004-08-26 Philippe Despres New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
EP2420242A1 (de) 2010-08-20 2012-02-22 Lauer, Ulrich M. Onkolytisches Masernvirus
CN104211769B (zh) * 2013-05-30 2018-08-03 中国科学院过程工程研究所 一种小分子抗体亲和肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617261A (en) * 1984-03-21 1986-10-14 Cetus Corporation Process for labeling nucleic acids and hybridization probes
JPS63307827A (ja) * 1987-06-08 1988-12-15 Kitasato Inst:The 安定化された生ウイルスワクチンおよびその製造法
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses

Also Published As

Publication number Publication date
US5824777A (en) 1998-10-20
KR950012759B1 (ko) 1995-10-21
DK0540135T3 (da) 2000-08-07
JPH05103665A (ja) 1993-04-27
DE69231143D1 (de) 2000-07-13
ES2148164T3 (es) 2000-10-16
EP0540135A2 (de) 1993-05-05
EP0540135B1 (de) 2000-06-07
EP0540135A3 (en) 1993-12-08
PT540135E (pt) 2000-11-30
JP3045581B2 (ja) 2000-05-29
KR930008138A (ko) 1993-05-21
US5654136A (en) 1997-08-05
GR3034278T3 (en) 2000-12-29
DE69231143T2 (de) 2000-10-19

Similar Documents

Publication Publication Date Title
ATE193726T1 (de) Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung
ATE238434T1 (de) Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren
ATE102993T1 (de) Virale expressionsinhibitoren.
ATE353973T1 (de) Die verwendung der 3'-wesentlichen bearbeitungswirksamkeit von dns-polymerase
DE69329636D1 (de) Verfahren zur Vervielfältigung von Nukleinsäuresequenzen
FI930658A0 (fi) Oligonukleotider foer modulering av effekten av cytomegalovirusinfektioner
FI893526A7 (fi) Välineitä ja menetelmä nukleiinihappohybridisaation lisäämiseksi
AU7319194A (en) Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines
NZ244089A (en) Characterising genomic dna samples into individual sample codes using amplification and type specific primers to form a database of individual sample codes
DE69019950D1 (de) Träger zur kultivierung von mikroorganismen, davon hergestellter träger zur kontrolle von parasitenbefall und verfahren zur parasitenbekämpfung.
ZA925259B (en) Immobilization of nucleic acids
EP0438292A3 (en) Method of preparing primers for polymerase chain reaction and dna amplification using said primers
CA2066998A1 (en) Recombinant varicella-zoster virus and process for constructing same
NO940658D0 (no) Nukleinsyre-polymerase-forökning
DK0527941T3 (da) Identifikation af hidtil ukendte lægemidler og reagenser
FI920636A7 (fi) DNA-koettimia ja alukkeita B. burgdorferin havaitsemiseksi polymeraasi ketjureaktiota käyttäen
DE68913128D1 (de) Verfahren zur Herstellung von L-Alanin-Dehydrogenase und Mikroorganismusstamm des Genus Sporolactobacillus.
DE3887710D1 (de) 1-(3,5-Di-0-benzoyl-2-deoxy-beta-D-threo-pentofuranosyl)Thymine und Verfahren zu deren Herstellung.
DK727688A (da) Malariaspecifikke dna-sekvenser, deres expressionsprodukter samt anvendelsen heraf
DE69230345D1 (de) Nachweis von einem genort
ATE108834T1 (de) Spezifische nukleinsäurefragmente des menschlichen villingens, ihre anwendung für diagnostische zwecke.
RU93013954A (ru) Способ обнаружения вируса иммунодефицита
NO875058L (no) Oligonukleotidprober og fremgangsmÿte for detektering av nukleinsyrene i bakterier og andre levende organismer ved hybridisering.
LV10311B (en) Method for the identification of microorganisms by the utilization of directed and arbitrary dna amplification
KR940012633U (ko) 핵산(dna) 증폭 배양기

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification